TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/23/21 17:27 | 4/21/21 | ETNB | 89Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grunberg Gregory | CA | D | S | -23 | 27.60 | 0 | -1 | 0 | 1,751 | D | |||||||||||||||
7/14/20 20:08 | 7/10/20 | ETNB | 89Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grunberg Gregory | CA | DT | P | 3,000 | 27.50 | 0 | 109 | 4 | 2,601 | I | |||||||||||||||
3/16/20 07:59 | 3/13/20 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grunberg Gregory | MA | D | P | 20,000 | 7.89 | 0 | 2,535 | 88 | 5,412 | I | |||||||||||||||
11/13/19 19:04 | 11/11/19 | ETNB | 89Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grunberg Gregory | CA | DT | P.d | 9,200 | 16.00 | 0 | 575 | 30 | 2,492 | I | |||||||||||||||
10/9/18 16:46 | 10/5/18 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grunberg Gregory | MA | D | P | 5,000 | 8.25 | 0 | 606 | 27 | 2,877 | I | |||||||||||||||
7/26/17 16:31 | 7/25/17 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Grunberg Gregory | MA | D | P.d | 3,225 | 15.00 | 0 | 215 | 10 | 2,271 | I |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |